Search Results - Navarro, Tasheda

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    The Bruton Tyrosine Kinase (Btk) Inhibitor ACP-196: Marked Activity in Relapsed/Refractory CLL with a Favorable Safety Profile

    The Bruton Tyrosine Kinase (Btk) Inhibitor ACP-196: Marked Activity in Relapsed/Refractory CLL with a Favorable Safety Profile by Byrd, John C., Wierda, William, Jones, Jeffrey, O'Brien, Susan, Brown, Jennifer R., Schuh, Anna, Hillmen, Peter, Stephens, Deborah M., Ghia, Paolo, Devereux, Steve, Chaves, Jorge M., Barrientos, Jacqueline C., Wang, Min Hui, Huang, Jane, Covey, Todd, Navarro, Tasheda, Rothbaum, Wayne, Izumi, Raquel, Hamdy, Ahmed, Furman, Richard R.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The Bruton's Tyrosine Kinase (BTK) Inhibitor PCI-32765 Induces Durable Responses in Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Follow-up of a Phase Ib/II Study

    The Bruton's Tyrosine Kinase (BTK) Inhibitor PCI-32765 Induces Durable Responses in Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL):... by O'Brien, Susan, Burger, Jan A., Blum, Kristie A., Furman, Richard R., Coutre, Steven E., Sharman, Jeff, Flinn, Ian W., Grant, Barbara, Heerema, Nyla A., Johnson, Amy J., Navarro, Tasheda, Holmgren, Eric, Hedrick, Eric, Byrd, John C.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: